期刊文献+

紫杉醇联合顺铂同步放化疗治疗中晚期宫颈癌的临床分析 被引量:3

The Clinical Research on Concurrent Radiotherapy and Chemotherapy by Paclitaxel plus Cisplatin in Advanced Cervical Cancer
下载PDF
导出
摘要 目的探讨同步放化疗治疗中晚期宫颈癌的疗效及毒副反应。方法2001年6月-2005年12月对黑龙江省林业第二医院同步放化疗组43例中晚期宫颈癌病人用紫杉醇联合顺铂治疗,同时行根治性放疗;单纯放疗组45例行根治性放疗。结果同步放化疗组近期有效率93%,单纯放疗组77.%。两组比较差异有显著性意义(P〈0.05),毒副反应相近。结论同步放化疗治疗中晚期宫颈癌可提高近期疗效,不影响放疗进程,毒副反应无明显增加。 Objective To observe the curative effects and side effects of concurrent radiotherapy and chemotherapy in advanced cervical cancer. Methods Is the study group (concurrent radiotherapy and chemotherapy ),43 pationts who had advanced cervical cancer were treated with concurrent radiotherapy and chemotherapy by paclitaxel plus cisplatin in the Second Forestry. Hospital of Hei longjiang Province from 2001.6 to 2005.12. At the same time,45 patients who had advanced cervical cancer were treated with radiotherapy alone as the control group ( radiotherapy alone ).Results Effective rate was 93.0% in the former and 77.0% in the latter. There was significant difference in effective rate between the two groups (P〈 0.05), no significant difference in side effect. Conclusion Concurrent radiotherapy and chemotherapy in advanced cervical cancer can improve the curative effect. The side effect is tolerable, and this method doesn't affect radiotherapy. [Key words] Advanced cervical cancer Paclitaxel plus cisplatin Concurrent radiotherapy and chemotherapy The curative effect The side effect
作者 韩梅
出处 《中华临床医学杂志》 2007年第2期35-37,共3页 Chinese Journal of Clinical Practical Medicine
关键词 中晚期宫颈癌 紫杉醇联合顺铂 同步放化疗 疗效 毒副反应 Advanced cervical cancer Paclitaxel plus cisplatin Concurrent radiotherapy and chemotherapy The curative effect The side effect
  • 相关文献

同被引文献38

  • 1邹红燕,赵晓利,姚安梅,王平.以顺铂为基础的不同化疗方案在宫颈癌同步放化疗中的疗效[J].现代肿瘤医学,2006,14(1):83-85. 被引量:9
  • 2吴煌坚,梁海斯,邵剑锋,何宝贞,张洁英,陈丽霞.同期放化疗治疗中晚期宫颈癌48例疗效观察[J].临床和实验医学杂志,2007,6(8):85-85. 被引量:4
  • 3张汉英,陈心秋,张桂丽,张惠煊.同步放化疗治疗中晚期宫颈癌的临床分析[J].海南医学院学报,2007,13(5):475-477. 被引量:7
  • 4Phippen NT,I.eath CA,Chino JP. Cost effectiveness of concurrent gemeitabine and cisplatin with radiation followed by adjuvant gemcitabine and eisplatin in patients with stages n B to 1V A carcinoma of the eervix[J]. Gyneeol Oneol,2012,127(2):267-272.
  • 5Kang S, Nam BH, Park JY. Risk assessment tool for distant after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: A Korean gynecologic oncology group study[J]. J Clin Oncol,2012,30(19)..2369-2374.
  • 6Lee H J, Kim YS, Shin SS. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical eancer[J]. Tumori,2012,98(5):615- 621.
  • 7l.iang Y, Bydder M, Yashar CM. Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies[J]. Int J Radiat Oncol Biol Phys,2013,85(2):406-414.
  • 8Villeneuve H, Desprcs P, Fortin B. Cervical lymph node metastases from unknown primary cancer: A single-institution experience with intensity-modulated radiotherapy[J]. Int J Radiat Oneol Biol Phys, 2012,82(5) 11866-1871.
  • 9李江宁.新辅助化疗在宫颈癌治疗中的临床疗效观察[J].中国医药科学,2012,2(5):69.
  • 10张晓玲.宫颈癌新辅助化疗的应用现状[J].中华现代妇产科学杂志,2009,6(4):150.

引证文献3

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部